









Markets
/
Stocks
/
nasdaq-hcwb
/

HCW Biologics Inc

HCWB

View Detailed Chart

4.125USD

-0.120-2.83%

Close 08/01, 16:00（ET）Quotes delayed by 15 min

4.63MMarket Cap

LossP/E TTM



HCW Biologics Inc

4.125

-0.120-2.83%

Overview Company Financials

Financials

Intraday

30m

Today

-2.83%

5 Days

-3.17%

1 Month

+1.60%

6 Months

-83.78%

Year to Date

-76.88%

1 Year

-82.95%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 1 analysts

BUY

Current Rating

35.000

Target Price

748.48%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

552

Total

Median

Average

Company name

Ratings

Analysts

HCW Biologics Inc

HCWB

CRISPR Therapeutics AG

CRSP

Intellia Therapeutics Inc

NTLA

Ionis Pharmaceuticals Inc

IONS

Exact Sciences Corp

EXAS

IQVIA Holdings Inc

IQV

...

111

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

15m

30m

15m

30m

D

Sell

Sell(9)

Neutral(3)

Buy(0)

Indicators

Sell(3)

Neutral(3)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

0.112

Neutral

RSI(14)

39.563

Neutral

STOCH(KDJ)(9,3,3)

26.837

Neutral

ATR(14)

0.319

High Vlolatility

CCI(14)

-115.870

Sell

Williams %R

88.048

Oversold

TRIX(12,20)

-0.533

Sell

StochRSI(14)

18.042

Sell

Moving Average

Sell(6)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MA5

4.245

Sell

MA10

4.295

Sell

MA20

4.351

Sell

MA50

5.233

Sell

MA100

7.393

Sell

MA200

12.497

Sell

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

HCW Biologics Inc. is a clinical-stage biopharmaceutical company. It is focused on discovering and developing novel immunotherapies to lengthen health span by disrupting the link between chronic, low-grade inflammation, and age-related diseases, such as cancer, cardiovascular diseases, diabetes, neurodegenerative diseases, autoimmune diseases, as well as other conditions such as long-haul COVID-19. It has developed a Tissue factOr-Based fusion (TOBI) discovery platform to generate designer, novel multi-functional fusion molecules with immunotherapeutic properties. Its lead product candidates include HCW9218 and HCW9302. HCW9218 is a bifunctional immunotherapeutic designed with the capabilities to neutralize transforming growth factor-β and stimulate immune cells, targeting senescent cells and the SASP factors they secrete. HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes. Its other product candidates include HCW9201, HCW9206, and others.

Ticker SymbolHCWB

CompanyHCW Biologics Inc

CEODr. Hing C. Wong, Ph.D.

Websitehttps://hcwbiologics.com/